Itolizumab: Antibody drug lowers risk of death in elderly Covid-19 patients

India’s Biocon Ltd said earlier this month it received regulatory approval in India for itolizumab for use in coronavirus infected patients with moderate-to-severe respiratory distress. It was originally tested as a treatment for psoriasis.

from Hindustan Times - topnews https://ift.tt/39NyPlI
via